Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Okopien

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Clinical Pharmacology and Therapeutics|October 21, 2009
The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokinesA Madej, L Buldak, M Basiak, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 29, 2001
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIbJ Kowalski, B Okopien, A Madej, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemiaJ Kowalski, B Okopien, A Madej, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 3, 2015
The emering role of helminths in treatment of the inflammatory bowel disordersD Szkudlapski, K Labuzek, Z Pokora, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 11, 1998
Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIbA Madej, B Okopien, J Kowalski, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemiaB Okopien, L Cwalina, M Lebek, et al.
Research Communications in Molecular Pathology and Pharmacology|February 3, 2005
The risk of atherosclerosis in patients with impaired glucose toleranceB Okopien, A Stachura-Kulach, A Kulach, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Clinical Pharmacology and Therapeutics|October 21, 2009
The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokinesA Madej, L Buldak, M Basiak, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 29, 2001
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIbJ Kowalski, B Okopien, A Madej, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemiaJ Kowalski, B Okopien, A Madej, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 3, 2015
The emering role of helminths in treatment of the inflammatory bowel disordersD Szkudlapski, K Labuzek, Z Pokora, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 11, 1998
Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIbA Madej, B Okopien, J Kowalski, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemiaB Okopien, L Cwalina, M Lebek, et al.
Research Communications in Molecular Pathology and Pharmacology|February 3, 2005
The risk of atherosclerosis in patients with impaired glucose toleranceB Okopien, A Stachura-Kulach, A Kulach, et al.
Pageof 3